A new-age for biologic therapies: Long-term drug-free therapy with BiP?

22Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Heat shock proteins (HSPs) and other members of the much broader stress protein family have been shown to play important roles in coordinating multiple phases of immunological reactions; from facilitating immunological recognition, to promoting and regulating immunological responses and finally augmenting the resolution of inflammation and return to immunological homeostasis. In this review, we consider the challenges facing the stress protein field as we enter 2012; in particular we consider the role that HSPs and stress proteins may play in the initiation and termination of immunological responses. Special attention is afforded to the resolution-associated molecular pattern, binding immunoglobulin protein (BiP, also known as glucose regulated protein-78). We review the evidence that resolution-promoting proteins such as BiP may herald a new generation of biologics for inflammatory disease and reflect on the challenges of achieving clinical remission in rheumatoid arthritis with novel therapeutics and correlating clinical remission with immunological parameters of resolution of inflammation. © 2012 Shields, Panayiand Corrigall.

Cite

CITATION STYLE

APA

Shields, A. M., Panayi, G. S., & Corrigall, V. M. (2012). A new-age for biologic therapies: Long-term drug-free therapy with BiP? Frontiers in Immunology. https://doi.org/10.3389/fimmu.2012.00017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free